• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconValeant

Valeant

Page 5 of 12
Senate Permanent Subcommittee On Investigations Hearing On U.S. Corporate Tax Code
HealthSenate Calls for Former Valeant CFO to Testify at Hearing
By Laura LorenzettiApril 26, 2016
Trading At The NYSE As  Valeant Shares Halted Ahead of News Announcement
HealthValeant Has Named Joseph Papa its New CEO
By ReutersApril 25, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
FinanceValeant Talking to Investment Banks to Weigh Asset Sales
By ReutersApril 15, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
HealthValeant’s CEO Just Avoided Contempt Charges From the U.S. Senate
By ReutersApril 13, 2016
The headquarters of Valeant Pharmaceuticals International, Inc. stands in  Bridgewater Township, U.S., on Wednesday Nov. 04, 2015. Photographer: Michael Nagle/Bloomberg
FinanceValeant Says It Has Received a Notice of Default
By Lucinda ShenApril 12, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
FinanceValeant Asks CEO Pearson to Cooperate With U.S. Senate Committee
By ReutersApril 11, 2016
Valeant To Buy Bausch & Lomb For $8.7 Billion
FinanceWhy Bill Ackman and Valeant Should Suck It Up and Sell Bausch & Lomb
By Jen WiecznerApril 8, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
FinanceBill Ackman Hints Who Valeant’s Next CEO Will Be
By Jen WiecznerApril 6, 2016
Squawk Box - Season 20
FinanceBill Ackman Is About to Get Seriously Grilled by Unhappy Investors
By ReutersApril 6, 2016
Trading At The NYSE As  Valeant Shares Halted Ahead of News Announcement
FinanceThis Is Why Valeant’s Shares Are Soaring
By Lucinda ShenApril 5, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
HealthSex Doesn’t Sell: Valeant Cutting Its ‘Female Viagra’ Sales Force
By ReutersApril 5, 2016
Trading At The NYSE As  Valeant Shares Halted Ahead of News Announcement
FinanceHere’s Why Moody’s Just Downgraded Valeant
By Jen WiecznerApril 1, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
FinanceBill Ackman Can’t Sell Valeant Even If He Wants To
By Lucinda ShenMarch 31, 2016
Trading At The NYSE As  Valeant Shares Halted Ahead of News Announcement
FinanceValeant Is Asking its Lenders for More Time to File its Annual Report
By ReutersMarch 30, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
FinanceValeant’s CEO Will Have to Testify at a U.S. Congressional Hearing
By ReutersMarch 28, 2016
1...
  • 3
  • 4
  • 5
  • 6
  • 7
...12
Most Popular
Innovation
An MIT roboticist who cofounded bankrupt robot vacuum maker iRobot says Elon Musk’s vision of humanoid robot assistants is ‘pure fantasy thinking’An image of a popular article
By Marco Quiroz-GutierrezFebruary 25, 2026
Success
Jeff Bezos says being lazy, not working hard, is the root of anxiety: ‘The stress goes away the second I take that first step’An image of a popular article
By Sydney LakeFebruary 25, 2026
Commentary
'The Pitt': a masterclass display of DEI in action An image of a popular article
By Robert RabenFebruary 26, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
Fortune Secondary Logo
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.